The Israel PTO announced last week that its PPH and PCT-PPH agreements with the European Patent Office, which were due to expire in January 2021, have been extended indefinitely. These programs allow applicants to expedite the examination of an application in one of these jurisdictions based on a positive examination report or PCT Written Opinion prepared in the other jurisdiction, without the payment of an additional fee to the relevant patent office. Download PPH & PCT-PPH ilpto epo 2020-10-29
The ILPTO has PPH and PCT-PPH agreements with the USA, EPO, Japan, and several other countries, as explained here.
Sadly, as explained in a previous blog post, PPH can be used to expedite examination, but the ILPTO has in recent years taken the (unnecessarily) stringent view that allowance of claims in Israel under section 17(c) of the statute may only be obtain on the basis of granted claims in an approved foreign jurisdiction, not on the basis of an allowance or an indication in a PCT WOISA that claims are allowable.